COMPANY · NIPC 500384045

LABORATORIO MEDINFAR-PRODUTOS FARMACEUTICOS S.A.

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €51,017,866.20 across 3,388 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameLABORATORIO MEDINFAR-PRODUTOS FARMACEUTICOS S.A.
NIPC500384045
Registered officeRUA HENRIQUE DE PAIVA COUCEIRO, Nº 29, FALAGUEIRA-VENDA NOVA, 2700-451 AMADORA
SourceGLEIF (LEI), registo 549300O2RCGBZ8067J81
Record date21 October 2026

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2012 to 2026. The table below gives the same values.2012: €1,718,701.3920122013: €3,590,490.552014: €8,194,299.5420142015: €8,172,046.982016: €859,850.3820162017: €1,841,462.122018: €1,445,238.5920182019: €2,919,074.232020: €3,812,397.5120202021: €2,422,926.822022: €3,670,900.7120222023: €3,276,827.222024: €3,110,865.7420242025: €4,120,994.542026: €1,861,789.882026€8,194,299.54
Contracted value by year
YearContractsContract value
201236€1,718,701.39
201346€3,590,490.55
2014110€8,194,299.54
201585€8,172,046.98
2016116€859,850.38
2017156€1,841,462.12
2018194€1,445,238.59
2019227€2,919,074.23
2020263€3,812,397.51
2021347€2,422,926.82
2022350€3,670,900.71
2023332€3,276,827.22
2024385€3,110,865.74
2025407€4,120,994.54
2026334€1,861,789.88
Contracted value by place of performance
NameContractsContract value
Coimbra163€15,875,757.60
Setúbal144€10,324,019.15
Évora62€5,262,003.45
Faro212€4,892,206.51
Lisboa574€4,751,849.50
Vila Real76€514,965.96
Maia58€510,048.39
Porto208€482,894.91
Oeiras100€329,635.25
Amadora87€278,806.65
Largest contracts
SubjectYearContract value
CPA 2013/50 - Medicamentos de consumo geral; medicamentos antialergicos; medicamentos usados no tratamento de intoxicação e grupo 20.92014€5,525,819.96
Medicamentos de consumo geral, medicação anti-alérgina, tratamento de intoxicações - C/ Base no CPA 2013/502015€4,903,295.61
Medicamentos do Foro Oncológico2013€2,333,105.08
Medicamentos anti-infecciosos excepto antivíricos e antifúngicos2015€1,249,190.34
Aquisição de Medicamentos Diversos.2021€1,125,100.97

Who they competed with

In 17,062 contracts with a list of competitors, the company took part and was awarded 1,217 (7%).

Companies with the most procedures in common
CompanyProcedures in common
generis farmaceutica sa1,560
ovwerpharma1,384
labesfal,, SA1,150
farmoz1,100
sandoz farmaceutica1,068
mylan1,021
hikma lda852
braun771
fresenius kabi pharma689
accord healthcare unipessoal, lda673
pfizer662
alloga639
gsk prod.farmaceuticos465
dla sa440
novartis farma436
unilfarma383
teva pharma382
angelini362
Genéricos - Comércio de Medicamentos S.A.358
pharmakern portugal355
Zentiva, Lda.313
Laboratórios Normon, SA297
sanofi-produtos farmaceuticos294
leo290
msd282
sidefarma lda282
tecnimede/Farmoz266
baxter263
tecnifar244
ferraz242

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents39 companies and 60 links. The list below gives the same content as text.novartis farma (NIPC 500063524)novartis farmasanofi-produto… (NIPC 500134960)sanofi-produto…gsk prod.farma… (NIPC 500139962)gsk prod.farma…pfizer (NIPC 500162166)pfizermsd (NIPC 500191360)msdunilfarma (NIPC 500293023)unilfarmaLABORATÓRIOS MEDINFAR - P… (NIPC 500384045)LABORATÓRIOS MEDINFAR - P…angelini (NIPC 500583650)angelinitecnimede/Farm… (NIPC 500626413)tecnimede/Farm…sidefarma lda (NIPC 500717419)sidefarma ldalabesfal,, SA (NIPC 501169580)labesfal,, SA+28 in the list below

Dotted: competed in the same procedure. Dotted: same procedure.

48 more links

Investigations that mention it

No published investigation mentions this company by NIPC.